无ADM或补片的胸肌前即刻假体乳房重建:210例患者349侧乳房前瞻性单术者系列
本研究为单中心、单术者前瞻性研究,纳入2023年9月至2025年3月接受Motiva Ergonomix2假体胸肌前即刻乳房重建的210例患者(349侧乳房),中位随访12个月。早期并发症发生率为26.1%,假体丢失率1.1%,包膜挛缩(III/IV级)7.7%,美容效果优良率>75%,BREAST-Q乳房满意度64.96%。结论认为该技术并发症和假体丢失率低,美容效果和患者满意度满意。
要点
- 胸肌前即刻假体重建不使用ADM或补片,早期并发症26.1%,假体丢失1.1%。
- 包膜挛缩(III/IV级)7.7%,假体波纹6%,非计划再手术8%。
- 美容效果优良率>75%,双侧预防性乳房切除者接近92%。
核心结论
- 该技术并发症和假体丢失率低,美容效果满意,患者报告满意度高,支持Ergonomix2假体作为胸肌前重建的安全、生物相容且可能成本效益好的选择。
研究设计与样本
- 前瞻性单中心、单术者研究,纳入2023年9月至2025年3月接受Motiva Ergonomix2假体胸肌前即刻乳房重建的患者,共210例(349侧乳房),中位随访12个月(范围3至21个月)。
主要发现
- 早期并发症发生于26.1%的乳房,最常见为切口裂开(5.2%)、血肿(3.7%)和部分乳头乳晕复合体(NAC)坏死(2.9%)。
- 美容效果(n=143)在>75%的病例中评为「优秀」或「良好」,双侧预防性乳房切除者接近92%。
- BREAST-Q(n=129)显示术后乳房满意度评分为64.96%,假体满意度为6.6/8。
临床怎么用
- 对于适合胸肌前即刻假体乳房重建的患者,可考虑使用4微米表面假体而不使用ADM或补片,以降低并发症和假体丢失风险。
局限性
- 单术者、单中心研究,随访时间中位12个月(范围3至21个月),美容效果和BREAST-Q分析样本量较小(分别为n=143和n=129)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prepectoral breast reconstruction reduces postoperative morbidity and eliminates animation deformity. Although acellular dermal matrices (ADM) and mesh have traditionally been used to stabilize prepectoral implants, emerging evidence has questioned their value and highlighted their association with postoperative complications. OBJECTIVES: This study presents a single-surgeon experience using 4-micron surface implants without ADM or mesh in immediate prepectoral direct-to-implant reconstruction. METHODS: This is a prospective single-center, single-surgeon study involving patients who underwent immediate prepectoral, breast reconstruction using Motiva Ergonomix2 implants, between September 2023 and March 2025. Early and mid-term complications, aesthetic outcomes, and patient-reported satisfaction (BREAST-Q) were analyzed. RESULTS: A total of 210 consecutive patients (349 breasts) underwent this surgical procedure with a median follow-up of 12 months (range: 3 to 21 months). Early complications occurred in 26.1% of breasts, most commonly incision dehiscence (5.2%), hematoma (3.7%), and partial nipple-areola-complex (NAC) necrosis (2.9%). Capsular contracture (Grade III/IV) occurred in 7.7% and implant rippling in 6%. Twenty-eight breasts (8%) required unplanned reoperation. Total implant loss occurred in 1.1% of breasts. Cosmetic outcomes (n=143) were rated "excellent" or "good" in >75% of cases, approaching 92% in bilateral prophylactic mastectomies. BREAST-Q responses (n=129) demonstrated a postoperative breast satisfaction score of 64.96%, and implant satisfaction of 6.6/8. CONCLUSIONS: This technique demonstrates low complication and implant loss rates, satisfactory aesthetic results, and high patient-reported satisfaction. These findings support Ergonomix2 implants as a safe, biocompatible, and potentially cost-effective option for prepectoral reconstruction.
引用
- Celet Ozden B, Sevindik GA, Yildirim N, et al. Prepectoral Direct-to-implant Breast Reconstruction Without ADM or Mesh: A Prospective Single-surgeon Series of 210 Patients and 349 Breasts. Aesthet Surg J. 2026. PMID: 42721297. doi:10.1093/asj/sjag191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。